BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/18/2022 7:25:42 AM | Browse: 200 | Download: 272
Publication Name World Journal of Psychiatry
Manuscript ID 71360
Country/Territory Taiwan
Received
2021-09-04 23:53
Peer-Review Started
2021-09-04 23:53
To Make the First Decision
Return for Revision
2021-11-08 03:45
Revised
2021-11-19 18:47
Second Decision
2022-07-08 02:52
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2022-07-11 19:16
Articles in Press
2022-07-11 19:16
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2022-08-09 12:50
Publish the Manuscript Online
2022-08-18 07:25
ISSN 2220-3206 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Psychiatry
Manuscript Type Letter to the Editor
Article Title Difference between treatment-resistant schizophrenia and clozapine-resistant schizophrenia
Manuscript Source Invited Manuscript
All Author List Ping-Tao Tseng, Mu-Hong Chen and Chih-Sung Liang
ORCID
Author(s) ORCID Number
Ping-Tao Tseng http://orcid.org/0000-0001-5761-7800
Mu-Hong Chen http://orcid.org/0000-0001-6516-1073
Chih-Sung Liang http://orcid.org/0000-0003-1138-5586
Funding Agency and Grant Number
Corresponding Author Chih-Sung Liang, MD, Assistant Professor, Attending Doctor, Department of Psychiatry, Beitou Branch, Tri-Service General Hospital, National Defense Medical Center, No. 60 Xinmin Road, Beitou District, Taipei 112, Taiwan. lcsyfw@gmail.com
Key Words Treatment-resistant schizophrenia; Clozapine; Clozapine-resistant schizophrenia; Ultra-resistant schizophrenia; Ultra-treatment-resistant schizophrenia; Super-refractory schizophrenia
Core Tip A diagnosis of clozapine-resistant schizophrenia (CRS) is made after administering an adequate trial of clozapine and excluding “pseudo-resistance” in patients who have been diagnosed with treatment-resistant schizophrenia (TRS). Disentangling the differences between TRS and CRS is important point for studies addressing treatment strategies for patients with CRS.
Publish Date 2022-08-18 07:25
Citation Tseng PT, Chen MH, Liang CS. Difference between treatment-resistant schizophrenia and clozapine-resistant schizophrenia. World J Psychiatry 2022; 12(8): 1102-1104
URL https://www.wjgnet.com/2220-3206/full/v12/i8/1102.htm
DOI https://dx.doi.org/10.5498/wjp.v12.i8.1102
Full Article (PDF) WJP-12-1102.pdf
Full Article (Word) WJP-12-1102.docx
Manuscript File 71360_Auto_Edited-LS.docx
Answering Reviewers 71360-Answering reviewers.pdf
Audio Core Tip 71360-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 71360-Conflict-of-interest statement.pdf
Copyright License Agreement 71360-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 71360-Language certificate.pdf
Peer-review Report 71360-Peer-review(s).pdf
Scientific Misconduct Check 71360-Bing-Wang JJ-2.png
Scientific Editor Work List 71360-Scientific editor work list.pdf